Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jul;140(1):13-22.
doi: 10.1007/s00418-013-1101-1. Epub 2013 Jun 8.

Review on intermediate filaments of the nervous system and their pathological alterations

Affiliations
Review

Review on intermediate filaments of the nervous system and their pathological alterations

Claire Lépinoux-Chambaud et al. Histochem Cell Biol. 2013 Jul.

Abstract

Intermediate filaments (IFs) of the nervous system, including neurofilaments, α-internexin, glial fibrillary acidic protein, synemin, nestin, peripherin and vimentin, are finely expressed following elaborated cell, tissue and developmental specific patterns. A common characteristic of several neurodegenerative diseases is the abnormal accumulation of neuronal IFs in cell bodies or along the axon, often associated with impairment of the axonal transport and degeneration of neurons. In this review, we also present several perturbations of IF metabolism and organization associated with neurodegenerative disorders. Such modifications could represent strong markers of neuronal damages. Moreover, recent data suggest that IFs represent potential biomarkers to determine the disease progression or the differential stages of a neuronal disorder. Finally, recent investigations on IF expression and function in cancer provide evidence that they may be useful as markers, or targets of brain tumours, especially high-grade glioma. A better knowledge of the molecular mechanisms of IF alterations, combined to neuroimaging, is essential to improve diagnosis and therapeutic strategies of such neurodegenerative diseases and glioma.

PubMed Disclaimer

References

    1. Cell Motil Cytoskeleton. 1992;22(2):81-91 - PubMed
    1. Neoplasma. 2009;56(4):284-90 - PubMed
    1. J Cell Biol. 1968 Sep;38(3):538-55 - PubMed
    1. Methods Mol Biol. 2011;689:183-204 - PubMed
    1. J Neurol Sci. 2012 Oct 15;321(1-2):39-42 - PubMed

Publication types

MeSH terms

LinkOut - more resources